China · Delayed Price · Currency is CNY Sino Biological,Inc. Statistics
Total Valuation
SHE:301047 has a market cap or net worth of CNY 8.96 billion. The enterprise value is 5.79 billion.
| Market Cap | 8.96B |
| Enterprise Value | 5.79B |
Important Dates
The last earnings date was Tuesday, April 14, 2026.
| Earnings Date | Apr 14, 2026 |
| Ex-Dividend Date | Sep 22, 2025 |
Share Statistics
SHE:301047 has 121.64 million shares outstanding. The number of shares has decreased by -4.93% in one year.
| Current Share Class | 121.64M |
| Shares Outstanding | 121.64M |
| Shares Change (YoY) | -4.93% |
| Shares Change (QoQ) | -0.03% |
| Owned by Insiders (%) | 55.81% |
| Owned by Institutions (%) | 4.24% |
| Float | 41.68M |
Valuation Ratios
The trailing PE ratio is 60.63 and the forward PE ratio is 50.79.
| PE Ratio | 60.63 |
| Forward PE | 50.79 |
| PS Ratio | 12.80 |
| PB Ratio | 1.69 |
| P/TBV Ratio | 1.79 |
| P/FCF Ratio | 198.42 |
| P/OCF Ratio | 61.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.95, with an EV/FCF ratio of 128.23.
| EV / Earnings | 39.18 |
| EV / Sales | 8.27 |
| EV / EBITDA | 31.95 |
| EV / EBIT | 64.17 |
| EV / FCF | 128.23 |
Financial Position
The company has a current ratio of 23.03, with a Debt / Equity ratio of 0.01.
| Current Ratio | 23.03 |
| Quick Ratio | 22.41 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | 1.19 |
| Interest Coverage | 29.22 |
Financial Efficiency
Return on equity (ROE) is 2.66% and return on invested capital (ROIC) is 4.08%.
| Return on Equity (ROE) | 2.66% |
| Return on Assets (ROA) | 0.97% |
| Return on Invested Capital (ROIC) | 4.08% |
| Return on Capital Employed (ROCE) | 1.67% |
| Weighted Average Cost of Capital (WACC) | 9.22% |
| Revenue Per Employee | 685,176 |
| Profits Per Employee | 144,697 |
| Employee Count | 1,021 |
| Asset Turnover | 0.12 |
| Inventory Turnover | 2.65 |
Taxes
In the past 12 months, SHE:301047 has paid 31.80 million in taxes.
| Income Tax | 31.80M |
| Effective Tax Rate | 17.71% |
Stock Price Statistics
The stock price has increased by +22.24% in the last 52 weeks. The beta is 0.91, so SHE:301047's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | +22.24% |
| 50-Day Moving Average | 72.41 |
| 200-Day Moving Average | 72.70 |
| Relative Strength Index (RSI) | 55.26 |
| Average Volume (20 Days) | 1,055,085 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:301047 had revenue of CNY 699.56 million and earned 147.74 million in profits. Earnings per share was 1.21.
| Revenue | 699.56M |
| Gross Profit | 509.09M |
| Operating Income | 90.21M |
| Pretax Income | 179.54M |
| Net Income | 147.74M |
| EBITDA | 155.34M |
| EBIT | 90.21M |
| Earnings Per Share (EPS) | 1.21 |
Balance Sheet
The company has 3.22 billion in cash and 53.52 million in debt, with a net cash position of 3.17 billion or 26.05 per share.
| Cash & Cash Equivalents | 3.22B |
| Total Debt | 53.52M |
| Net Cash | 3.17B |
| Net Cash Per Share | 26.05 |
| Equity (Book Value) | 5.31B |
| Book Value Per Share | 43.69 |
| Working Capital | 3.37B |
Cash Flow
In the last 12 months, operating cash flow was 146.19 million and capital expenditures -101.05 million, giving a free cash flow of 45.14 million.
| Operating Cash Flow | 146.19M |
| Capital Expenditures | -101.05M |
| Depreciation & Amortization | 65.33M |
| Net Borrowing | n/a |
| Free Cash Flow | 45.14M |
| FCF Per Share | 0.37 |
Margins
Gross margin is 72.77%, with operating and profit margins of 12.90% and 21.12%.
| Gross Margin | 72.77% |
| Operating Margin | 12.90% |
| Pretax Margin | 25.66% |
| Profit Margin | 21.12% |
| EBITDA Margin | 22.20% |
| EBIT Margin | 12.90% |
| FCF Margin | 6.45% |
Dividends & Yields
This stock pays an annual dividend of 5.20, which amounts to a dividend yield of 7.01%.
| Dividend Per Share | 5.20 |
| Dividend Yield | 7.01% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 411.67% |
| Buyback Yield | 4.93% |
| Shareholder Yield | 10.25% |
| Earnings Yield | 1.65% |
| FCF Yield | 0.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on March 30, 2022. It was a forward split with a ratio of 1.9.
| Last Split Date | Mar 30, 2022 |
| Split Type | Forward |
| Split Ratio | 1.9 |
Scores
SHE:301047 has an Altman Z-Score of 22.8 and a Piotroski F-Score of 3.
| Altman Z-Score | 22.8 |
| Piotroski F-Score | 3 |